Berlin, Germany - Germany's BioNTech and US pharmaceutical giant Pfizer on Thursday announced "positive" results from initial trials of their combined mRNA vaccine against Covid-19 and influenza. Phase one and two trials of the vaccine had produced "robust immune responses" against both illnesses and showed a "safety profile consistent with the...